06/09/2018
The year 2017/2018 has been very successful for Hamlet Pharma. The company has reached several important milestones and targets, and has initiated of the drug candidate Alpha1H on patients. We are proud to have kept the promises made to our investors. Read the year-end report on our website in Swedish:http://hamletpharma.com/download/del%C3%A5rsrapporter/Bokslutskommunike-17-18_30-aug-2018_final.pdf